ATE238825T1 - Antihypertensives mittel - Google Patents

Antihypertensives mittel

Info

Publication number
ATE238825T1
ATE238825T1 AT97305820T AT97305820T ATE238825T1 AT E238825 T1 ATE238825 T1 AT E238825T1 AT 97305820 T AT97305820 T AT 97305820T AT 97305820 T AT97305820 T AT 97305820T AT E238825 T1 ATE238825 T1 AT E238825T1
Authority
AT
Austria
Prior art keywords
antihypertensive agent
effective amount
pro
day
producing
Prior art date
Application number
AT97305820T
Other languages
English (en)
Inventor
Naoyuki Yamamoto
Original Assignee
Calpis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co Ltd filed Critical Calpis Co Ltd
Application granted granted Critical
Publication of ATE238825T1 publication Critical patent/ATE238825T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/80—Antihypertensive peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97305820T 1996-08-02 1997-08-01 Antihypertensives mittel ATE238825T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20466596 1996-08-02

Publications (1)

Publication Number Publication Date
ATE238825T1 true ATE238825T1 (de) 2003-05-15

Family

ID=16494265

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97305820T ATE238825T1 (de) 1996-08-02 1997-08-01 Antihypertensives mittel
AT02080463T ATE374617T1 (de) 1996-08-02 1997-08-01 Verfahren zur herstellung eines bluddrucksenkenden mittel enthaltenden ein dipeptid als wirksames bestandteil

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT02080463T ATE374617T1 (de) 1996-08-02 1997-08-01 Verfahren zur herstellung eines bluddrucksenkenden mittel enthaltenden ein dipeptid als wirksames bestandteil

Country Status (8)

Country Link
US (1) US5854029A (de)
EP (2) EP0821968B1 (de)
JP (2) JP3364579B2 (de)
AT (2) ATE238825T1 (de)
DE (2) DE69721407T2 (de)
DK (2) DK1302207T3 (de)
ES (2) ES2196263T3 (de)
PT (1) PT1302207E (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6998259B1 (en) 1999-05-20 2006-02-14 Davisco Foods International Enzymatic treatment of whey proteins for the production of antihypertensive peptides and the resulting products
US6630320B1 (en) 2000-05-08 2003-10-07 Devisco Foods International, Inc. Treatment of hypertension in mammals with hydrolyzed whey proteins
FI113741B (fi) 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
TWI225070B (en) 1999-12-01 2004-12-11 Food Industry Res & Dev Inst Novel peptides used as angiotensin converting enzyme inhibitor and preparation process thereof
AU2001245537A1 (en) * 2000-03-10 2001-09-24 Monsanto Company Anti-hypertensive peptides
AU2001247334A1 (en) * 2000-03-10 2001-09-24 Monsanto Company Novel peptides with anti-hypertensive activity
CA2415688A1 (en) * 2000-05-08 2001-11-15 Anand Rao Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals
EP1529114A1 (de) 2002-08-09 2005-05-11 Chr. Hansen A/S Verfahren für die herstellung von peptiden mit blutdrucksenkenden eigenschaften
US7718171B2 (en) 2003-04-07 2010-05-18 Chr. Hansen A/S Reducing heart rate in mammals using milk derived fermentation products produced using Lactobacillus helveticus
EP1466529A1 (de) * 2003-04-07 2004-10-13 Chr. Hansen A/S Präparat mit herzfrequenzsenkenden Eigenschaften
JP4680571B2 (ja) * 2003-12-25 2011-05-11 カルピス株式会社 経口摂取用保湿剤
BRPI0514903A (pt) 2004-09-03 2008-06-24 Hansens Lab proteìnas vegetais ou leite fermentado compreendendo ligando de receptor e uso dos mesmos
JP4868619B2 (ja) * 2005-09-05 2012-02-01 独立行政法人農業・食品産業技術総合研究機構 ビタミンＵ、タウリン、カルノシン、Ｔｙｒ−Ｐｒｏおよび／またはＬ−カルニチンを高濃度に含有する食用植物体及びその製造方法
JP4635159B2 (ja) * 2005-09-05 2011-02-16 独立行政法人農業・食品産業技術総合研究機構 Ｇａｂａを高濃度に含有する食用植物体及びその製造方法
EP2161028B1 (de) * 2008-09-09 2011-01-05 Unilever N.V. Nahrungsmittel enthaltend Dipeptide mit blutdrucksenkenden Eigenschaften.
EP2161029A1 (de) * 2008-09-09 2010-03-10 Unilever N.V. Zusammensetzung, die Peptide umfasst
MX2011010077A (es) * 2009-03-27 2011-10-11 Calpis Co Ltd Composicion para regular la actividad nerviosa autonoma y metodo para regular el nervio autonomo.
CN103221531B (zh) * 2010-11-09 2018-03-16 朝日集团控股株式会社 具有高蛋白质水解活性的瑞士乳杆菌
US8673862B1 (en) 2012-09-06 2014-03-18 Food Industry Research And Development Institute Peptides and use thereof in the inhibition of angiotensin converting enzyme
US10780127B2 (en) 2016-06-23 2020-09-22 National University Corporation Tottori University Method for producing fermented milk having high angiotensin converting enzyme inhibitory activity and method for producing physiologically active peptide
JP7453665B2 (ja) * 2019-01-29 2024-03-21 国立大学法人鳥取大学 ジペプチジルペプチダーゼｉｖ阻害活性が高い発酵乳およびその製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3047596A1 (de) * 1980-12-17 1982-07-22 Victor Dipl.- Chem. 8000 München Brantl Pharmakologisch aktive dipeptide
JP3782837B2 (ja) * 1995-04-10 2006-06-07 カルピス株式会社 血圧降下剤及びその製造法

Also Published As

Publication number Publication date
EP1302207A3 (de) 2003-04-23
DE69738185D1 (de) 2007-11-15
DK1302207T3 (da) 2007-11-05
PT1302207E (pt) 2007-11-08
EP0821968A3 (de) 1999-07-14
JP2003048849A (ja) 2003-02-21
EP0821968B1 (de) 2003-05-02
EP1302207B1 (de) 2007-10-03
JP4713053B2 (ja) 2011-06-29
ES2196263T3 (es) 2003-12-16
EP1302207A2 (de) 2003-04-16
DE69721407T2 (de) 2004-05-06
ES2291417T3 (es) 2008-03-01
DE69721407D1 (de) 2003-06-05
ATE374617T1 (de) 2007-10-15
DE69738185T2 (de) 2008-07-10
EP0821968A2 (de) 1998-02-04
JP3364579B2 (ja) 2003-01-08
JPH1095736A (ja) 1998-04-14
US5854029A (en) 1998-12-29
DK0821968T3 (da) 2003-06-02

Similar Documents

Publication Publication Date Title
DE69721407D1 (de) Antihypertensives Mittel
PL323152A1 (en) Derivatives of 1,3-propanodiole as biologically active compounds
GB2319250B (en) Derivatives of 6,8-Difluoro-7-Hydroxycoumarin
AU3215597A (en) Method of inhibiting fibrosis with a somatostatin agonist
AU7360887A (en) Pharmacologically active 1,5-diarly-3-substituted- pyrazoles and method for synthesizing the same
PL332432A1 (en) Oxadiazoles, method of obtaining them as well as their application as therapeutic agents
GR3036669T3 (en) O-carbamoyl-phenylalaninol having substituent at benzene ring, its pharmaceutically useful salts and method for preparing the same
PL328771A1 (en) Derivatives of 4-aminopyrimidine, therapeutic agents containing such compounds, their application and method of obtaining such compounds
HUP9900457A3 (en) Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
MX9802383A (es) Derivados de pirimidina como antagonistas del receptor 5ht26.
IT1299982B1 (it) Metodo per la realizzazione di pacchetti di sigarette ed impianto per l'attuazione di tale metodo.
PL338563A1 (en) Substituted derivatives of 1,2,3,4-tetrahydronaphtalene
WO1993000094A3 (en) Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine
PL329121A1 (en) Substituted derivatives of 1,2,3,4-tetrahydronaphtalene
PL322802A1 (en) Derivatives of 10,13,15-trioxatricyclo[9.2.1.1]-pentadecanone, method of obtaining them and therapeutic agents containing such compounds
FI941776A7 (fi) Menetelmä 1,2,4-tiadiatsolien valmistamiseksi
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
GB9601779D0 (en) 9, 10 Disubstituted camptothecin derivatives
EP0127124A3 (de) Verbindungen zur Behandlung von hohem Blutdruck
BG106151A (en) Pharmaceutical complex
EP0846465A4 (de) Heilmittel für angstneurosen
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
DE69622415D1 (de) 12H-Dibenzo[d,g][1,3]dioxocin Derivate
BG103986A (en) Derivatives of pyrrolidinecarboxylic acids as endotheline antagonists
PL331444A1 (en) Derivatives of 11-acetyl-12,13-dioxabicyclo[8.2.1]tridecenone, method of obtaining them and drugs containing such compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties